Market Cap

Spago Nanomedical AB Market Capitalization:

kr76.2 Million

SEK as of Jan. 1, 2024

US$7.6 Million

business Spago Nanomedical AB Company Profile

Spago Nanomedical AB Main Stock Listing

OMX: SPAGO

Market Capitalization History of Spago Nanomedical AB

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Biotechnology
Company Market Cap (USD)
Novo Nordisk $461.52 B
Vertex Pharmaceuticals Incorporated $107.23 B
Regeneron Pharmaceuticals, Inc. $100.01 B
CSL Limited $94.74 B
Marinomed Biotech AG $73.23 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $586.39 B
UnitedHealth Group $504.47 B
Novo Nordisk $461.52 B
Johnson & Johnson $387.50 B
Merck $296.51 B

Yearly evolution of Spago Nanomedical AB market cap

Date Market Cap YoY Change
Jan. 1, 2024 kr76.2 M -1.96%
Jan. 1, 2023 kr77.7 M -80.77%
Jan. 1, 2022 kr404.1 M -42.56%
Jan. 1, 2021 kr703.5 M -29.72%
Jan. 1, 2020 kr1.00 B 9.88%
Jan. 1, 2019 kr911.1 M 2.90%
Jan. 1, 2018 kr885.4 M -16.55%
Jan. 1, 2017 kr1.06 B -6.72%
Jan. 1, 2016 kr1.14 B 29.38%
Jan. 1, 2015 kr879.1 M -18.46%
Jan. 1, 2014 kr1.08 B 0.00%
Jan. 1, 2013 kr1.08 B

Market capitalization is calculated from the opening stock price at the beginning of each year.

Top 1-year algo backtest: +269.94%

$10,000 in May 2023 would now be $36,994 by following this algorithm daily at market close.

Boost your stocks returns with Disfold AI... Now!

Try Disfold AI for FREE

Spago Nanomedical AB Categories

Sweden languages Healthcare languages Biotechnology
Sweden Healthcare Sweden Biotechnology

Stocks & Indices

Spago Nanomedical AB has the following listings and related stock indices.


Stock: OMX: SPAGO

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.